Progress in Translational Regulatory T Cell Therapies for Type 1 Diabetes and Islet Transplantation
出版年份 2020 全文链接
标题
Progress in Translational Regulatory T Cell Therapies for Type 1 Diabetes and Islet Transplantation
作者
关键词
-
出版物
ENDOCRINE REVIEWS
Volume -, Issue -, Pages -
出版商
The Endocrine Society
发表日期
2020-11-28
DOI
10.1210/endrev/bnaa028
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Regulatory T Cells and Human Disease
- (2020) Shimon Sakaguchi et al. Annual Review of Immunology
- Low Dose IL-2 Combined with Rapamycin Led to an Expansion of CD4+CD25+FOXP3+ Tregs and Prolonged Human Islet-allograft Survival in Humanized Mice
- (2020) Min Hu et al. DIABETES
- Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
- (2020) Birgit Sawitzki et al. LANCET
- Therapeutic Effects of BCG Vaccination on Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2020) Yu-Chen Chang et al. Journal of Diabetes Research
- 116-OR: Comparison of Pancreas vs. Islet Transplantation Outcomes from a Large Single Center
- (2020) BRAULIO A. MARFIL-GARZA et al. DIABETES
- Effects of tacrolimus (FK506) and mycophenolate mofetil (MMF) on regulatory T cells and co-inhibitory receptors in the peripheral blood of human liver allograft patients
- (2019) Qiang Zeng et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
- (2019) Michael J. Haller et al. DIABETES
- A new era of genetic engineering for autoimmune and inflammatory diseases
- (2019) Dave Ewart et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Current state of organ transplant tolerance
- (2019) Charles G. Rickert et al. Current Opinion in Organ Transplantation
- Standardisation of flow cytometry for whole blood immunophenotyping of islet transplant and transplant clinical trial recipients
- (2019) Elvira Jimenez Vera et al. PLoS One
- Next-generation regulatory T cell therapy
- (2019) Leonardo M. R. Ferreira et al. NATURE REVIEWS DRUG DISCOVERY
- Long‐term outcome of islet transplantation on insulin‐dependent diabetes mellitus: An observational cohort study
- (2019) Toshihiro Nakamura et al. Journal of Diabetes Investigation
- Applicability, Safety And Biological Activity Of Regulatory T Cell Therapy In Liver Transplantation
- (2019) Alberto Sánchez‐Fueyo et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immunomodulation Followed By Antigen-Specific Treg Infusion Controls Islet Autoimmunity
- (2019) Cecilia Cabello-Kindelan et al. DIABETES
- Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study
- (2019) Marie-Christine Vantyghem et al. DIABETES CARE
- Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases
- (2019) Maryam Tahvildari et al. JOURNAL OF IMMUNOLOGY
- Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model
- (2019) Daniel R. Holohan et al. PLoS One
- CRISPRa-mediated FOXP3 gene upregulation in mammalian cells
- (2019) Vida Forstnerič et al. Cell and Bioscience
- CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis
- (2018) Fatemeh Safari et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Functional Interrogation of Primary Human T Cells via CRISPR Genetic Editing
- (2018) Xin Chen et al. JOURNAL OF IMMUNOLOGY
- Regulatory T cells in autoimmune disease
- (2018) Margarita Dominguez-Villar et al. NATURE IMMUNOLOGY
- Over ten-year insulin independence following single allogeneic islet transplant without T-cell depleting antibody induction
- (2018) Jack Williams et al. Islets
- c-Jun N-terminal kinase 1 defective CD4+CD25+FoxP3+ cells prolong islet allograft survival in diabetic mice
- (2018) Deepak Tripathi et al. Scientific Reports
- A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants
- (2018) James M. Mathew et al. Scientific Reports
- Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial
- (2018) Sandrine Lablanche et al. Lancet Diabetes & Endocrinology
- A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
- (2018) Kayleigh M. van Megen et al. Frontiers in Immunology
- Gene Therapy With Regulatory T Cells: A Beneficial Alliance
- (2018) Moanaro Biswas et al. Frontiers in Immunology
- Foxp3+ T Regulatory Cells: Still Many Unanswered Questions—A Perspective After 20 Years of Study
- (2018) Ethan M. Shevach Frontiers in Immunology
- Emerging Functions of Regulatory T Cells in Tissue Homeostasis
- (2018) Amit Sharma et al. Frontiers in Immunology
- Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations
- (2018) Willem M. Kühtreiber et al. npj Vaccines
- Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis
- (2018) Ana Luisa Perdigoto et al. DIABETOLOGIA
- The number of FoxP3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: A multistage systematic review
- (2018) Francisco Herrera-Gómez et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Treg cells—the next frontier of cell therapy
- (2018) Jeffrey A. Bluestone et al. SCIENCE
- Preparation of Immunotolerant Space Under the Skin and Transplantation of Islets in the Space
- (2018) Rei Kuwabara et al. TISSUE ENGINEERING PART A
- Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine
- (2018) Bart O Roep et al. Lancet Diabetes & Endocrinology
- Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance
- (2018) Qunfang Zhang et al. Frontiers in Immunology
- CRISPR knock out CTLA-4 enhances the anti-tumor activity of cytotoxic T lymphocytes
- (2017) Long Shi et al. GENE
- Transplant trials with Tregs: perils and promises
- (2017) Qizhi Tang et al. JOURNAL OF CLINICAL INVESTIGATION
- Autoreactive T cells in type 1 diabetes
- (2017) Alberto Pugliese JOURNAL OF CLINICAL INVESTIGATION
- Recuentos de células T reguladoras en sangre periférica como biomarcador predictivo del resultado del trasplante renal: revisión sistemática
- (2017) Francisco Herrera-Gómez et al. MEDICINA CLINICA
- Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes
- (2017) Mohammad Alhadj Ali et al. Science Translational Medicine
- Treg therapy in transplantation: a general overview
- (2017) Marco Romano et al. TRANSPLANT INTERNATIONAL
- Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections
- (2017) Deborah Jane Holmes-Walker et al. TRANSPLANTATION
- Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells
- (2017) Masahiro Okada et al. Epigenetics & Chromatin
- Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
- (2017) Kelen C. R. Malmegrim et al. Frontiers in Immunology
- Human Tregs Made Antigen Specific by Gene Modification: The Power to Treat Autoimmunity and Antidrug Antibodies with Precision
- (2017) Patrick R. Adair et al. Frontiers in Immunology
- Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression
- (2017) Guido Sebastiani et al. Scientific Reports
- Treg-Centric View of Immunosuppressive Drugs in Transplantation: A Balancing Act
- (2016) G. Camirand et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Phenotypical characterization of regulatory T cells in humans and rodents
- (2016) A. L. Rodríguez-Perea et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Cytokine-based immune monitoring
- (2016) O.Millán et al. CLINICAL BIOCHEMISTRY
- A Regulatory T-Cell Gene Signature Is a Specific and Sensitive Biomarker to Identify Children With New-Onset Type 1 Diabetes
- (2016) Anne M. Pesenacker et al. DIABETES
- A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation
- (2016) Satoru Todo et al. HEPATOLOGY
- Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?
- (2016) Anabelle Visperas et al. JOURNAL OF IMMUNOLOGY
- Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway
- (2016) Andrew B. Adams et al. JOURNAL OF IMMUNOLOGY
- Clinical pancreatic islet transplantation
- (2016) A. M. James Shapiro et al. Nature Reviews Endocrinology
- The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients
- (2016) Annick Massart et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Impact of Immune-Modulatory Drugs on Regulatory T Cell
- (2016) Akiko Furukawa et al. TRANSPLANTATION
- Induced Regulatory T Cells: Their Development, Stability, and Applications
- (2016) Mitsuhiro Kanamori et al. TRENDS IN IMMUNOLOGY
- Type 1 diabetes vaccine candidates promote human Foxp3+Treg induction in humanized mice
- (2016) Isabelle Serr et al. Nature Communications
- Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
- (2016) John A. Todd et al. PLOS MEDICINE
- Long-Term Follow-Up of the Edmonton Protocol of Islet Transplantation in the United States
- (2015) D. C. Brennan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Comparative Analysis of the Safety, Efficacy, and Cost of Islet Versus Pancreas Transplantation in Nonuremic Patients With Type 1 Diabetes
- (2015) S. Moassesfar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Alginate Encapsulant Incorporating CXCL12 Supports Long-Term Allo- and Xenoislet Transplantation Without Systemic Immune Suppression
- (2015) T. Chen et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry
- (2015) Saskia J. A. M. Santegoets et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunological Shielding by Induced Recruitment of Regulatory T-Lymphocytes Delays Rejection of Islets Transplanted in Muscle
- (2015) Evelina Vågesjö et al. CELL TRANSPLANTATION
- Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance
- (2015) Hanyu Zeng et al. Cellular & Molecular Immunology
- Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus — A randomized clinical trial
- (2015) Gerlies Treiber et al. CLINICAL IMMUNOLOGY
- Tolerance signatures in transplant recipients
- (2015) Kenneth A. Newell et al. Current Opinion in Organ Transplantation
- Accessory cells for β-cell transplantation
- (2015) W. Staels et al. DIABETES OBESITY & METABOLISM
- Effects of High-Dose Oral Insulin on Immune Responses in Children at High Risk for Type 1 Diabetes
- (2015) Ezio Bonifacio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
- (2015) Michelle Rosenzwajg et al. JOURNAL OF AUTOIMMUNITY
- Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
- (2015) Mark R. Rigby et al. JOURNAL OF CLINICAL INVESTIGATION
- Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3highregulatory T cells in humans
- (2015) Makoto Miyara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Type 1 diabetes immunotherapy using polyclonal regulatory T cells
- (2015) Jeffrey A. Bluestone et al. Science Translational Medicine
- The need for minimization strategies: current problems of immunosuppression
- (2015) Jamal Bamoulid et al. TRANSPLANT INTERNATIONAL
- Coaggregates of Regulatory T Cells and Islet Cells Allow Long-term Graft Survival in Liver Without Immunosuppression
- (2015) Naohiro Takemoto et al. TRANSPLANTATION
- Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation
- (2015) Niloufar Safinia et al. Frontiers in Immunology
- Therapy of type 1 diabetes with CD4+CD25highCD127-regulatory T cells prolongs survival of pancreatic islets — Results of one year follow-up
- (2014) Natalia Marek-Trzonkowska et al. CLINICAL IMMUNOLOGY
- Interleukin 2 in the Pathogenesis and Therapy of Type 1 Diabetes
- (2014) Michelle Rosenzwajg et al. Current Diabetes Reports
- Islet cell transplant and the incorporation of Tregs
- (2014) Adam Krzystyniak et al. Current Opinion in Organ Transplantation
- Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes
- (2014) Ronnie Aronson et al. DIABETES CARE
- Once a Treg, always a Treg?
- (2014) Deepali V. Sawant et al. IMMUNOLOGICAL REVIEWS
- IL-7 receptor blockade following T cell depletion promotes long-term allograft survival
- (2014) Hoa-Le Mai et al. JOURNAL OF CLINICAL INVESTIGATION
- Attenuation of Donor-Reactive T Cells Allows Effective Control of Allograft Rejection Using Regulatory T Cell Therapy
- (2013) K. Lee et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis
- (2013) Sofia V. Abrahamsson et al. BRAIN
- Homeostatic T Cell Proliferation after Islet Transplantation
- (2013) Paolo Monti et al. Clinical & Developmental Immunology
- Evidence for Rapamycin Toxicity in Pancreatic β-Cells and a Review of the Underlying Molecular Mechanisms
- (2013) Adam D. Barlow et al. DIABETES
- Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
- (2013) K. C. Herold et al. DIABETES
- B-Lymphocyte Depletion With Rituximab and -Cell Function: Two-Year Results
- (2013) M. D. Pescovitz et al. DIABETES CARE
- Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
- (2013) Tihamer Orban et al. DIABETES CARE
- Efficacy and safety of low-dose otelixizumab anti-CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes: DEFEND-2, a randomized, placebo-controlled, double-blind, multi-centre study
- (2013) P. Ambery et al. DIABETIC MEDICINE
- Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients
- (2013) Carlos Benítez et al. HEPATOLOGY
- The Ubiquitin Ligase Stub1 Negatively Modulates Regulatory T Cell Suppressive Activity by Promoting Degradation of the Transcription Factor Foxp3
- (2013) Zuojia Chen et al. IMMUNITY
- Impact of alemtuzumab treatment on the survival and function of human regulatory T cellsin vitro
- (2013) Evis Havari et al. IMMUNOLOGY
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- (2013) Antoinette Moran et al. LANCET
- Immune surveillance by the liver
- (2013) Craig N Jenne et al. NATURE IMMUNOLOGY
- Novel Sphingosine-1-Phosphate Receptor Modulator KRP203 Combined With Locally Delivered Regulatory T Cells Induces Permanent Acceptance of Pancreatic Islet Allografts
- (2013) Mithun Khattar et al. TRANSPLANTATION
- Foxp3+Regulatory T Cells in Mouse Models of Type 1 Diabetes
- (2013) Cathleen Petzold et al. Journal of Diabetes Research
- Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial
- (2013) Mark R Rigby et al. Lancet Diabetes & Endocrinology
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial
- (2013) Stephen E Gitelman et al. Lancet Diabetes & Endocrinology
- Natural and Induced T Regulatory Cells in Cancer
- (2013) Dennis O. Adeegbe et al. Frontiers in Immunology
- Potent Induction Immunotherapy Promotes Long-Term Insulin Independence After Islet Transplantation in Type 1 Diabetes
- (2012) M. D. Bellin et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Induction of Allograft Tolerance by Monoclonal CD3 Antibodies: A Matter of Timing
- (2012) S. You et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Lymphodepletion and Homeostatic Proliferation: Implications for Transplantation
- (2012) N. K. Tchao et al. AMERICAN JOURNAL OF TRANSPLANTATION
- FoxP3+, and not CD25+, T cells increase post-transplant in islet allotransplant recipients following anti-CD25+ rATG immunotherapy
- (2012) Kelly Hire et al. CELLULAR IMMUNOLOGY
- Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs -Cell Function
- (2012) S. A. Long et al. DIABETES
- Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes
- (2012) L. Piemonti et al. DIABETES
- Administration of CD4+CD25highCD127- Regulatory T Cells Preserves -Cell Function in Type 1 Diabetes in Children
- (2012) N. Marek-Trzonkowska et al. DIABETES CARE
- Improvement in Outcomes of Clinical Islet Transplantation: 1999-2010
- (2012) F. B. Barton et al. DIABETES CARE
- IL-7 Abrogates Suppressive Activity of Human CD4+CD25+FOXP3+ Regulatory T Cells and Allows Expansion of Alloreactive and Autoreactive T Cells
- (2012) A.-K. Heninger et al. JOURNAL OF IMMUNOLOGY
- Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes
- (2012) Denise L. Faustman et al. PLoS One
- Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation
- (2012) Pervinder Sagoo et al. Frontiers in Immunology
- Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A Paradigm of Immunodeficiency with Autoimmunity
- (2012) Federica Barzaghi et al. Frontiers in Immunology
- Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly
- (2011) A. Veerapathran et al. BLOOD
- The battle against immunopathology: infectious tolerance mediated by regulatory T cells
- (2011) David M. Gravano et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Do CD4+Foxp3+ Treg cells correlate with transplant outcomes: A systematic review on recipients of solid organ transplantation
- (2011) Juan Shan et al. CELLULAR IMMUNOLOGY
- Expansion of Th17 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancreatic Lymph Nodes in Patients With Type 1 Diabetes
- (2011) Alessandra Ferraro et al. DIABETES
- Suppression assays with human T regulatory cells: A technical guide
- (2011) Alicia N. McMurchy et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes
- (2011) Laura Espino-Paisan et al. IMMUNOGENETICS
- Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets
- (2011) Joel Montane et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti-CD3 Therapy Promotes Tolerance by Selectively Depleting Pathogenic Cells while Preserving Regulatory T Cells
- (2011) C. Penaranda et al. JOURNAL OF IMMUNOLOGY
- Plasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes
- (2011) Stephanie A. McClymont et al. JOURNAL OF IMMUNOLOGY
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
- (2011) Nicole Sherry et al. LANCET
- Reduced Progression of Diabetic Microvascular Complications With Islet Cell Transplantation Compared With Intensive Medical Therapy
- (2011) David M. Thompson et al. TRANSPLANTATION
- A Genome-Wide Meta-Analysis of Six Type 1 Diabetes Cohorts Identifies Multiple Associated Loci
- (2011) Jonathan P. Bradfield et al. PLoS Genetics
- Experience with a Novel Efalizumab-Based Immunosuppressive Regimen to Facilitate Single Donor Islet Cell Transplantation
- (2010) N. A. Turgeon et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance
- (2010) Dusan Hanidziar et al. Current Opinion in Organ Transplantation
- No Effect of the 1 ,25-Dihydroxyvitamin D3 on -Cell Residual Function and Insulin Requirement in Adults With New-Onset Type 1 Diabetes
- (2010) M. Walter et al. DIABETES CARE
- Failure to Preserve -Cell Function With Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients With New- Onset Type 1 Diabetes
- (2010) P. A. Gottlieb et al. DIABETES CARE
- An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4+ T cells
- (2010) S A Long et al. GENES AND IMMUNITY
- Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity
- (2010) Thomas R. Malek et al. IMMUNITY
- IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
- (2010) Yenkel Grinberg-Bleyer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response
- (2010) Zhigang Fan et al. NATURE MEDICINE
- Islet Transplantation in Type 1 Diabetic Patients Using Calcineurin Inhibitor-Free Immunosuppressive Protocols Based on T-Cell Adhesion or Costimulation Blockade
- (2010) Andrew M. Posselt et al. TRANSPLANTATION
- Regulatory T-Cell Counter-Regulation by Innate Immunity Is a Barrier to Transplantation Tolerance
- (2009) J. I. Kim et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Antigen-Specific Dependence of Tr1-Cell Therapy in Preclinical Models of Islet Transplant
- (2009) N. Gagliani et al. DIABETES
- Etanercept Treatment in Children With New-Onset Type 1 Diabetes: Pilot randomized, placebo-controlled, double-blind study
- (2009) L. Mastrandrea et al. DIABETES CARE
- Immunological aspects of pancreatic islet cell transplantation
- (2009) Jamil Azzi et al. Expert Review of Clinical Immunology
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
- (2009) Makoto Miyara et al. IMMUNITY
- Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells
- (2009) Hélène Bour-Jordan et al. IMMUNOLOGICAL REVIEWS
- In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression
- (2009) Kylie E. Webster et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conversion From Calcineurin Inhibitor to Mycophenolate Mofetil-Based Immunosuppression Changes the Frequency and Phenotype of CD4+FOXP3+ Regulatory T Cells
- (2009) Ahmet Demirkiran et al. TRANSPLANTATION
- Differential Effect of Cyclosporine and Mycophenolic Acid on the Human Regulatory T Cells and TH-17 Cells Balance
- (2009) F. Abadja et al. TRANSPLANTATION PROCEEDINGS
- Prolonged Insulin Independence After Islet Allotransplants in Recipients with Type 1 Diabetes
- (2008) M. D. Bellin et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The Effect of Costimulatory and Interleukin 2 Receptor Blockade on Regulatory T Cells in Renal Transplantation
- (2008) J. A. Bluestone et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Long-Term Insulin-Independence After Allogeneic Islet Transplantation for Type 1 Diabetes: Over the 10-Year Mark
- (2008) T. Berney et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study
- (2008) S. L. Thrower et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Analysis of islet inflammation in human type 1 diabetes
- (2008) A. Willcox et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4+CD25+FOXP3+ Regulatory T-Cells
- (2008) P. Monti et al. DIABETES
- Presence of FoxP3+ Regulatory T Cells Predicts Outcome of Subclinical Rejection of Renal Allografts
- (2008) O. Bestard et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mechanism of cellular rejection in transplantation
- (2008) Elizabeth Ingulli PEDIATRIC NEPHROLOGY
- Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation
- (2008) Volkert A. L. Huurman et al. PLoS One
- Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation
- (2008) Christian Toso et al. TRANSPLANT INTERNATIONAL
- FoxP3 in Peripheral Blood Is Associated With Operational Tolerance in Liver Transplant Patients During Immunosuppression Withdrawal
- (2008) José A. Pons et al. TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search